USANA Health Sciences Falls on Lowered Full-Year Profit Guidance, Swing to 3Q Loss

Dow Jones

Oct 10, 2025

By Kelly Cloonan

Shares of USANA Health Sciences declined after the nutritional-supplements company said it expects lower full-year earnings than it previously forecast after swinging to a third-quarter loss.

The stock slid 11%, to $23.25, in late trading Thursday. Shares are down 27% this year through market close.

The company said Thursday it now expects earnings per share to be below its prior guidance range of $1.50 to $2.20 for the year.

It also forecasts sales for the full year at or near the lower end of its previous outlook of $920 million to $1 billion.

The updated guidance reflects a lower base of active customer counts entering the fourth quarter after softer-than-expected sales in the third quarter.

The recent quarter's results were also hurt by a more pronounced slowdown than anticipated during the rollout of an improved brand partner compensation plan, the company said.

USANA's preliminary third-quarter results show a loss of $6.5 million, or 36 cents a share, compared with a profit of $10.6 million, or 56 cents a share, a year earlier.

The company expects an adjusted loss per share of 15 cents.

Revenue is expected to rise to $214 million compared with $200 million a year ago.

The company expects to update its outlook when it publishes its final third-quarter results after market close on Oct. 21.

Write to Kelly Cloonan at kelly.cloonan@wsj.com

(END) Dow Jones Newswires

October 09, 2025 19:16 ET (23:16 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

LOGIN / SIGN UP

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2574118439"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2574118439\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2574118439?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-10 07:16","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2574118439","market":"nz","top_or_hot":-1,"title":"USANA Health Sciences Falls on Lowered Full-Year Profit Guidance, Swing to 3Q Loss","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of USANA Health Sciences declined after the nutritional-supplements company said it expects lower full-year earnings than it previously forecast after swinging to a third-quarter loss. \n</p>\n<p>\n  The stock slid 11%, to $23.25, in late trading Thursday. Shares are down 27% this year through market close. \n</p>\n<p>\n  The company said Thursday it now expects earnings per share to be below its prior guidance range of $1.50 to $2.20 for the year. \n</p>\n<p>\n  It also forecasts sales for the full year at or near the lower end of its previous outlook of $920 million to $1 billion. \n</p>\n<p>\n  The updated guidance reflects a lower base of active customer counts entering the fourth quarter after softer-than-expected sales in the third quarter. \n</p>\n<p>\n  The recent quarter's results were also hurt by a more pronounced slowdown than anticipated during the rollout of an improved brand partner compensation plan, the company said. \n</p>\n<p>\n  USANA's preliminary third-quarter results show a loss of $6.5 million, or 36 cents a share, compared with a profit of $10.6 million, or 56 cents a share, a year earlier. \n</p>\n<p>\n  The company expects an adjusted loss per share of 15 cents. \n</p>\n<p>\n  Revenue is expected to rise to $214 million compared with $200 million a year ago. \n</p>\n<p>\n  The company expects to update its outlook when it publishes its final third-quarter results after market close on Oct. 21. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 09, 2025 19:16 ET (23:16 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>USANA Health Sciences Falls on Lowered Full-Year Profit Guidance, Swing to 3Q Loss</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUSANA Health Sciences Falls on Lowered Full-Year Profit Guidance, Swing to 3Q Loss\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2025-10-10 07:16</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  By Kelly Cloonan \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Shares of USANA Health Sciences declined after the nutritional-supplements company said it expects lower full-year earnings than it previously forecast after swinging to a third-quarter loss. \n</p>\n<p>\n  The stock slid 11%, to $23.25, in late trading Thursday. Shares are down 27% this year through market close. \n</p>\n<p>\n  The company said Thursday it now expects earnings per share to be below its prior guidance range of $1.50 to $2.20 for the year. \n</p>\n<p>\n  It also forecasts sales for the full year at or near the lower end of its previous outlook of $920 million to $1 billion. \n</p>\n<p>\n  The updated guidance reflects a lower base of active customer counts entering the fourth quarter after softer-than-expected sales in the third quarter. \n</p>\n<p>\n  The recent quarter's results were also hurt by a more pronounced slowdown than anticipated during the rollout of an improved brand partner compensation plan, the company said. \n</p>\n<p>\n  USANA's preliminary third-quarter results show a loss of $6.5 million, or 36 cents a share, compared with a profit of $10.6 million, or 56 cents a share, a year earlier. \n</p>\n<p>\n  The company expects an adjusted loss per share of 15 cents. \n</p>\n<p>\n  Revenue is expected to rise to $214 million compared with $200 million a year ago. \n</p>\n<p>\n  The company expects to update its outlook when it publishes its final third-quarter results after market close on Oct. 21. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  October 09, 2025 19:16 ET (23:16 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4532","symbol_name":"文艺复兴科技持仓","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2574118439","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2574118439","pubTimestamp":1760051760,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Shares of USANA Health Sciences declined after the nutritional-supplements company said it expects lower full-year earnings than it previously forecast after swinging to a third-quarter loss.The stock slid 11%, to $23.25, in late trading Thursday. Shares are down 27% this year through market close.The company said Thursday it now expects earnings per share to be below its prior guidance range of $1.50 to $2.20 for the year.It also forecasts sales for the full year at or near the lower end of its previous outlook of $920 million to $1 billion.The updated guidance reflects a lower base of active customer counts entering the fourth quarter after softer-than-expected sales in the third quarter.The recent quarter's results were also hurt by a more pronounced slowdown than anticipated during the rollout of an improved brand partner compensation plan, the company said.USANA's preliminary third-quarter results show a loss of $6.5 million, or 36 cents a share, compared with a profit of $10.6 mi","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4532":"文艺复兴科技持仓","USNA":"优莎娜","BK4183":"个人用品"},"translate_title":"USANA Health Sciences因全年利润指引下调而下跌，第三季度亏损","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"USNA":0.9},"content_text":"By Kelly Cloonan \n\n\n \n\n\n  Shares of USANA Health Sciences declined after the nutritional-supplements company said it expects lower full-year earnings than it previously forecast after swinging to a third-quarter loss. \n\n\n  The stock slid 11%, to $23.25, in late trading Thursday. Shares are down 27% this year through market close. \n\n\n  The company said Thursday it now expects earnings per share to be below its prior guidance range of $1.50 to $2.20 for the year. \n\n\n  It also forecasts sales for the full year at or near the lower end of its previous outlook of $920 million to $1 billion. \n\n\n  The updated guidance reflects a lower base of active customer counts entering the fourth quarter after softer-than-expected sales in the third quarter. \n\n\n  The recent quarter's results were also hurt by a more pronounced slowdown than anticipated during the rollout of an improved brand partner compensation plan, the company said. \n\n\n  USANA's preliminary third-quarter results show a loss of $6.5 million, or 36 cents a share, compared with a profit of $10.6 million, or 56 cents a share, a year earlier. \n\n\n  The company expects an adjusted loss per share of 15 cents. \n\n\n  Revenue is expected to rise to $214 million compared with $200 million a year ago. \n\n\n  The company expects to update its outlook when it publishes its final third-quarter results after market close on Oct. 21. \n\n\n \n\n\n  Write to Kelly Cloonan at kelly.cloonan@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 09, 2025 19:16 ET (23:16 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"dataReport","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}